Antiretroviral therapy availability and HIV disclosure to spouse in Rakai, Uganda: A longitudinal population-based study

Journal of Acquired Immune Deficiency Syndromes

Volumn 69, Issue 2, 2015, Pages 241-247

  Haberlen, Sabina A ^a   Nakigozi, Gertrude ^b   Gray, Ronald H ^a   Brahmbhatt, Heena ^a   Ssekasanvu, Joseph ^b   Serwadda, David ^b   Nalugoda, Fred ^b   Kagaayi, Joseph ^b   Wawer, Maria J ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

Author keywords

antiretroviral therapy; disclosure; discrete time survival analysis; HIV counseling; HIV AIDS; stigma

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTERPERSONAL COMMUNICATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PRIORITY JOURNAL; RISK REDUCTION; SELF DISCLOSURE; SEROCONVERSION; SEXUAL TRANSMISSION; SPOUSE; UGANDA; DISEASE TRANSMISSION; HEALTH CARE DELIVERY; HIV INFECTIONS; INFORMATION PROCESSING; PREVENTION AND CONTROL; PSYCHOLOGY; UTILIZATION;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DATA COLLECTION; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; SELF DISCLOSURE; SPOUSES; UGANDA;

EID: 84929863718     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000600     Document Type: Article

References (29)

1. Maman S, Mbwambo JK, Hogan NM, et al. High rates and positive outcomes of HIV-serostatus disclosure to sexual partners: reasons for cautious optimism from a voluntary counseling and testing clinic in Dar es Salaam, Tanzania. AIDS Behav. 2003;7:373-382.
2. King R, Katuntu D, Lifshay J, et al. Processes and outcomes of HIV serostatus disclosure to sexual partners among people living with HIV in Uganda. AIDS Behav. 2008;12:232-243.
3. Medley AM, Kennedy CE, Lunyolo S, et al. Disclosure outcomes, coping strategies, and life changes among women living with HIV in Uganda. Qual Health Res. 2009;19:1744-1754.
4. Medley A, Garcia-Moreno C, McGill S, et al. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ. 2004;82:299-307.
5. Chesney MA, Smith AW. Critical delays in HIV testing and care-The potential role of stigma. Am Behav Sci. 1999;42:1162-1174.
6. Antelman G, Smith Fawzi MC, Kaaya S, et al. Predictors of HIV-1 serostatus disclosure: A prospective study among HIV-infected pregnant women in Dar es Salaam, Tanzania. AIDS. 2001;15:1865-1874.
7. World Health Organization, UNAIDS, UNICEF. Epidemic Update and Health Sector Progress towards Universal Access: Progress Report 2011. Geneva, Switzerland: WHO; 2011.
8. World Health Organization. Treating 3 Million by 2005: Making it Happen. Geneva, Switzerland: WHO; 2011.
9. Brou H, Djohan G, Becquet R, et al. When do HIV-infected women disclose their HIV status to their male partner and why? A study in a PMTCT programme, Abidjan. PLoS Med. 2007;4:e342.
10. Maman S, Medley A. Gender Dimensions of HIV Status Disclosure to Sexual Partners: Rates, Barriers, and Outcomes. Geneva, Switzerland: World Health Organization; 2004.
11. Miller NA, Rubin DL. Factors leading to self-disclosure of a positive HIV diagnosis in Nairobi, Kenya: people living with HIV/AIDS in the Sub-Sahara. Qual Health Res. 2007;17:586-598.
12. Nachega JB, Lehman DA, Hlatshwayo D, et al. HIV/AIDS and antiretroviral treatment knowledge, attitudes, beliefs, and practices in HIV-infected adults in Soweto, South Africa. J Acquir Immune Defic Syndr. 2005;38:196-201.
13. Skogmar S, Shakely D, Lans M, et al. Effect of antiretroviral treatment and counselling on disclosure of HIV-serostatus in Johannesburg, South Africa. AIDS Care. 2006;18:725-730.
14. Wawer MJ, Gray RH, Sewankambo NK, et al. A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS. 1998;12:1211-1225.
15. Matovu JK, Gray RH, Makumbi F, et al. Voluntary HIV counseling and testing acceptance, sexual risk behavior and HIV incidence in Rakai, Uganda. AIDS. 2005;19:503-511.
16. Matovu JK, Kigozi G, Nalugoda F, et al. The Rakai Project counselling programme experience. Trop Med Int Health. 2002;7:1064-1067.
17. Singer JD, Willett JB. It's about time: using discrete-time survival analysis to study duration and the timing of events. J Educ Stat. 1993;18:155-195.
18. Waddell EN, Messeri PA. Social support, disclosure, and use of antiretroviral therapy. AIDS Behav. 2006;10:263-272.
19. Sayles JN, Wong MD, Cunningham WE. The inability to take medications openly at home: does it help explain gender disparities in HAART use? J Womens Health (Larchmt). 2006;15:173-181.
20. Unge C, Johansson A, Zachariah R, et al. Reasons for unsatisfactory acceptance of antiretroviral treatment in the urban Kibera slum, Kenya. AIDS Care. 2008;20:146-149.
21. Stirratt MJ, Remien RH, Smith A, et al. The role of HIV serostatus disclosure in antiretroviral medication adherence. AIDS Behav. 2006;10:483-493.
22. Rintamaki LS, Davis TC, Skripkauskas S, et al. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS. 2006;20:359-368.
23. Klitzman RL, Kirshenbaum SB, Dodge B, et al. Intricacies and interrelationships between HIV disclosure and HAART: A qualitative study. AIDS Care. 2004;16:628-640.
24. Castro A, Farmer P. Understanding and addressing AIDS-related stigma: from anthropological theory to clinical practice in Haiti. Am J Public Health. 2005;95:53-59.
25. Genberg BL, Hlavka Z, Konda KA, et al. A comparison of HIV/AIDSrelated stigma in four countries: negative attitudes and perceived acts of discrimination towards people living with HIV/AIDS. Soc Sci Med. 2009;68:2279-2287.
26. Maman S, Abler L, Parker L, et al. A comparison of HIV stigma and discrimination in five international sites: The influence of care and treatment resources in high prevalence settings. Soc Sci Med. 2009;68: 2271-2278.
27. Wolfe WR, Weiser SD, Leiter K, et al. The impact of universal access to antiretroviral therapy on HIV stigma in Botswana. Am J Public Health. 2008;98:1865-1871.
28. Maman S, Mbwambo J, Hogan NM, et al. Women's barriers to HIV-1 testing and disclosure: challenges for HIV-1 voluntary counselling and testing. AIDS Care. 2001;13:595-603.
29. Akani CI, Erhabor O. Rate, pattern and barriers of HIV serostatus disclosure in a resource-limited setting in the Niger delta of Nigeria. Trop Doct. 2006;36:87-89.